Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))-Reference-Cited by-同舟云学术

Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))

Published:2010-05-20 Issue:9 Volume:69 Page:1629-1635
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Annals of the Rheumatic Diseases

Author:

Emery P.,Deodhar A.,Rigby W. F.,Isaacs J. D.,Combe B.,Racewicz A. J.,Latinis K.,Abud-Mendoza C.,Szczepanski L. J.,Roschmann R. A.,Chen A.,Armstrong G. K.,Douglass W.,Tyrrell H.

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Cited by 282 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing Immunogenicity and Safety following Transition from Reference Rituximab to Biosimilar Rituximab (DRL_RI) in patients with Rheumatoid Arthritis: A Randomized, Double- blind, Phase 3 Study;2024-08-11

2. Systematic review and meta-analysis for the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis;Modern Rheumatology;2024-05-30

3. B-cell depletion in autoimmune diseases;Annals of the Rheumatic Diseases;2024-05-22

4. Non-TNF biologics and their biosimilars in rheumatoid arthritis;Expert Opinion on Biological Therapy;2024-05-22

5. Low-dose rituximab treatment in a patient with anti-neurofascin-155 IgG4 autoimmune nodopathy;Journal of Neuroimmunology;2024-04